Medical decision making: how patients choose. Med Decis Making. 2010;30(5 Suppl):8S–10S..
Communicating evidence for participatory decision making. JAMA. 2004;291(19):2359–66., , .
A systematic review on communicating with patients about evidence. Eval Clin Pract. 2006;12(1):13–23., , , , .
Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers. J Clin Oncol. 2010;28(2):222–31., , .
Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction. Health Psychology. 2009;28(1):11–9., , , et al.
Development of an interactive decision aid for female BRCA1/BRCA2 carriers. J Genet Couns. 2003;12:109–29., , , et al.
Online tool to guide decisions for BRCA1/2 mutation carriers. J Clin Oncol. 2012;30(5):497–506., , , et al.
2009(3):CD001431., , , et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database of Systematic Reviews (Online).
Decisions for dummies. CMAJ. 2009;181(5):E78..
Decision analysis: introductory lectures on choices under uncertainty. 1st ed. New York: Random House; 1968..
Theory of games and economic behavior. Princeton, NJ: Princeton University Press; 1944., .
Utility functions for life years and health status. Oper Res. 1980;28(1):206–24., , .
The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247–63., , .
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–83., .
An inventory for measuring depression. Archives of Gen Psych. 1961;4:53–63., , , ,
Methods for measuring temporary health states for cost-utility analyses. PharmacoEconomics. 2009;27(9):713–23., , , , .
Patients’ utilities for cancer treatments: a study of the chained procedure for the standard gamble and time tradeoff. Med Decis Making. 1998;18(4):391–9., , , et al.
Valuing health states: a comparison of methods. J Health Econ. 1996;15(2):209–31., , , .
The measurement of contingent valuation for health economics. PharmacoEconomics. 2004;22(11):691–700..
When do the “dollars” make sense? Toward a conceptual framework for contingent valuation studies in health care. Med Decis Making. 1996;16(3):288–99., .
The importance of perspective in the measurement of quality-adjusted life years. Med Decis Making. 1997;17(1):33–41., .
Modeling ranking, time trade-off, and visual analog scale values for EQ-5D health states: a review and comparison of methods. Med Care. 2009;47(6):634–41., , .
Reconsidering the use of rankings in the valuation of health states: a model for estimating cardinal values from ordinal data. Population Health Metrics. 2003;1(1):12..
Rescaling quality of life values from discrete choice experiments for use as QALYs: a cautionary tale. Population Health Metrics. 2008;6:6., , , , .
Conducting discrete choice experiments to inform healthcare decision making: a user’s guide. PharmacoEconomics. 2008;26(8):661–77., .
2010 disability weights measurement study. Lancet. in press., , , et al. Common values in assessing health outcomes from disease and injury: Global Burden of Disease
Measurement of health state utilities for economic appraisal. J Health Econ. 1986;5(1):1–30..
Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. Med Care. 1996;34:702–22., , , et al.
A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ. 2010;11(2):215–25., , , .
The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271–92., , .
The estimation of a preference-based measure of health from the SF-12. Med Care. 2004;42(9):851–9., .
Modeling valuations for EuroQol health states. Med Care. 1997;35(11):1095–108..
Multi-attribute health status classification systems. Health utilities index. PharmacoEconomics. 1995;7:490–502., , , .
Multi-attribute preference functions. Health Utilities Index. PharmacoEconomics. 1995;7(6):503–20., , , .
EuroQol--a new facility for the measurement of health-related quality of life. The EuroQol Group. Health policy (Amsterdam, Netherlands). 1990;16(3):199–208..
Health utility elicitation: is there still a role for direct methods?PharmacoEconomics. 2012;30(2):83–6., , .
An off-the-shelf help list: a comprehensive catalog of preference scores from published cost-utility analyses. Med Decis Making. 2001;21(4):288–94., , , , .
Relative disutilities of 47 risk factors and conditions assessed with seven preference-based health status measures in a national U.S. sample: toward consistency in cost-effectiveness analyses. Med Care. 2006;44(5):478–85., , .
Measuring preferences for health states worse than death. Med Decis Making. 1994;14:9–18., , , , .
Protocols for time tradeoff valuations of health states worse than dead: a literature review. Med Decis Making. 2010;30(5):610–9., , , .
On the assessment of preferences for health and duration: maximal endurable time and better than dead preferences. Med Care. 2007;45(9):835–41., , , .
A note on QALYs, time tradeoff, and discounting. Med Decis Making. 1994;14:188–93., , .
Time preference, the discounted utility model and health. J Health Econ. 1996;15(1):49–66., .
The validity of QALYs: an experimental test of constant proportional tradeoff and utility independence. Med Decis Making. 1997;17(1):21–32., .
A criticism of healthy-years equivalents. Med Decis Making. 1996;16(3):207–14..
Thinking about it: thoughts about health and valuing QALYs. Health Econ. 2011;20(12):1407–16..
Measuring constructed preferences: toward a building code. J Risk Uncertainty. 1999;19(1–3):243–70., .
Choices, values and frames. Amer Psychologist. 1984;39:341–50.,
The influence of framing on risky decisions: a meta-analysis. Org Behav Hum Decis Processes. 1998;75:23–55..
On the elicitation of preferences for alternative therapies. N Engl J Med. 1982;306:1259–62., , , .
Ordering errors, objections and invariance in utility survey responses: a framework for understanding who, why and what to do. Applied Health Econ Health Policy. 2011;9(4):225–41., .
Cost-effectiveness in health and medicine. 1st ed. New York: Oxford University Press; 1996., , , .
QALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critique. Expert Rev Pharmacoecon Outcomes Res. 2010;10(3):293–308., , , .
Guide to the Methods of Technology Appraisal. London: NICE 2008..
Guidelines for Preparing Submissions to the Pharmaceutical Benefits Advisory Committee. Canberra ACT: Department of Health and Aging 2008..
Guidelines for the economic evaluation of health technologies. Ottawa, Canada 2006..
Valuing Health for Regulatory Cost-Effectiveness Analysis. Washington, DC: Institute of Medicine, National Academies Press; 2006., , , editors.
A comparison of EQ-5D index scores derived from the US and UK population-based scoring functions. Med Decis Making. 2007;27(3):321–6., , , .